Tissue Regenix Group Plc
WHO'M
ai
Digital Profiler. Simply click the AI button
FIGI: -
TRX
Tissue Regenix Group Plc
GICS: -
·
Sector: -
·
Sub-Sector: -
NAME
Tissue Regenix Group Plc
ISIN
GB00B5SGVL29
TICKER
TRX
MIC
XLON
REUTERS
TRX.L
BLOOMBERG
TRX LN
Financial Intelligence
FOR INVESTORS
FOR TRADERS
Securities Trading
Warrants
EQS Newswire is a major provider of regulatory and corporate news. It mainly serves companies, investors and media worldwide. Through its services, EQS Newswire enables efficient and secure communication between companies and their stakeholders. Its main services include the distribution of ad hoc announcements, corporate news and the publication of financial reports that meet strict international standards.
Mon, 23.09.2024
Hardman & Co Research on Tissue Regenix (TRX):
Maiden pre-tax profit
TRX is focused on the development and commercialisation of two proprietary processing technologies for the repair of soft tissue (dCELL®) and bone (BioRinse®). It has a broad portfolio of products used in biosurgery, orthopaedics and dental markets. Investment in tissue ...
Mon, 23.09.2024
Hardman & Co Research on Tissue Regenix (TRX):
Maiden pre-tax profit
TRX is focused on the development and commercialisation of two proprietary processing technologies for the repair of soft tissue (dCELL®) and bone (BioRinse®). It has a broad portfolio of products used in biosurgery, orthopaedics and dental markets. Investment in tissue ...
Tue, 25.06.2024
Hardman & Co Insight: Survival of the UK life sciences sector
For two years running, the Hardman & Co Healthcare index has declined, underperforming both the FTSE 100 and the FTSE All-Share indices. This is quite unusual for healthcare stocks. Apart from the general economic influences, which have made institutions more risk-averse, the...
Wed, 10.04.2024
Hardman & Co Research on Tissue Regenix (TRX):
Six consecutive periods of >20% growth
TRX is focused on the development and commercialisation of two proprietary processing technologies for the repair of soft tissue (dCELL®) and bone (BioRinse®). It has a broad portfolio of products used in biosurgery, orthopaedics and dental markets. I...
Information on product placements
